Sleep Disorders Trial, Recruiting (NCT07498712)

Sleep Disorders Trial, Recruiting NCT07498712 Sponsor: Lactomason Co., Ltd. Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT07498712 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults (both men and women) between the ages of 19 and 65 who are generally healthy
People who score 5 or higher on a standard sleep quality questionnaire called the Pittsburgh Sleep Quality Index, which measures how well someone sleeps
People who have agreed to take part and signed a consent form

Who may not be able to join:

People whose sleep disorder scores fall outside a certain range on a standard insomnia questionnaire (either very severe or very mild, as measured by the Insomnia Severity Index) (confirm with trial site)
People who have a medical condition known to cause sleep problems, such as sleep apnea, restless legs syndrome, depression, or narcolepsy
People who have taken any medications that affect sleep in the month before their first trial visit
People who have consumed probiotics or fermented milk products (such as yogurt drinks or kefir) in the month before their first trial visit

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 12 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 82-55-360-5988

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07498712

Sponsor: Lactomason Co., Ltd.

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

Trial contact: 82-55-360-5988

More information: https://clinicaltrials.gov/study/NCT07498712

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults (both men and women) between the ages of 19 and 65 who are generally healthy
People who score 5 or higher on a standard sleep quality questionnaire called the Pittsburgh Sleep Quality Index, which measures how well someone sleeps
People who have agreed to take part and signed a consent form

Who may not be able to join:

People whose sleep disorder scores fall outside a certain range on a standard insomnia questionnaire (either very severe or very mild, as measured by the Insomnia Severity Index) (confirm with trial site)
People who have a medical condition known to cause sleep problems, such as sleep apnea, restless legs syndrome, depression, or narcolepsy
People who have taken any medications that affect sleep in the month before their first trial visit
People who have consumed probiotics or fermented milk products (such as yogurt drinks or kefir) in the month before their first trial visit

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 12 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Lactomason Co., Ltd.

Registry

ClinicalTrials.gov

Start date

14 July 2025

Est. completion

27 March 2026

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Change from Baseline in Sleep Efficiency (SE); Change from Baseline in Sleep Latency (SL); Change from Baseline in Total Sleep Time (TST); Change from Baseline in Wake After Sleep Onset (WASO); Change from Baseline in Delta Power; Change in Pittsburgh Sleep Quality Index (PSQI) Total Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov